Ilan Linder
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment
Papers in
-
- Pharmacological Effects and Toxicity Studies 3
- Pediatric Urology and Nephrology Studies 1
-
- Epilepsy research and treatment 5
- Child Nutrition and Feeding Issues 1
- Co-authors
- Tally Lerman‐Sagie (4 shared papers)Shay Menascu (2 shared papers)Uri Kramer (2 shared papers)T. Lerman‐Sagie (3 shared papers)Orna Epstein (1 shared paper)Bruria Ben‐Zeev (1 shared paper)Michal Tzadok (1 shared paper)Omer Bar Yosef (1 shared paper)
In The Last Decade
Ilan Linder
11 papers receiving 321 citations
Peers
Comparison fields: 5 of 54
- Pharmacology 177
- Psychiatry and Mental health 91
- Cellular and Molecular Neuroscience 87
- Pharmacy 11
- Pediatrics, Perinatology and Child Health 40
Countries citing papers authored by Ilan Linder
This map shows the geographic impact of Ilan Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Linder more than expected).
Fields of papers citing papers by Ilan Linder
This network shows the impact of papers produced by Ilan Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Linder. The network helps show where Ilan Linder may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilan Linder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 165 | |
| 2 | 2016 | 44 | |
| 3 | 2018 | 43 | |
| 4 | 2007 | 24 | |
| 5 | 2012 | 20 | |
| 6 | 2011 | 19 | |
| 7 | 2022 | 8 | |
| 8 | 2024 | 3 | |
| 9 | Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE. | 2020 | 2 |
| 10 | 2022 | 1 | |
| 11 | 2017 | 1 | |
| 12 | 2022 | 0 |
About Ilan Linder
Ilan Linder is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Pharmacology, Genetics and Infectious Diseases, having authored 12 papers that have together received 330 indexed citations. Recurring topics across this work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cannabis and Cannabinoid Research (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Genomics and Rare Diseases (1 paper), Bartonella species infections research (1 paper), Pediatric Urology and Nephrology Studies (1 paper) and Child Nutrition and Feeding Issues (1 paper). The work is most often cited by research in Pharmacology (177 citations), Psychiatry and Mental health (91 citations), Cellular and Molecular Neuroscience (87 citations), Pharmacy (11 citations) and Pediatrics, Perinatology and Child Health (40 citations). Ilan Linder has collaborated with scholars based in Israel, Belgium and Australia. Frequent co-authors include Tally Lerman‐Sagie, Shay Menascu, Uri Kramer, T. Lerman‐Sagie, Orna Epstein, Bruria Ben‐Zeev, Michal Tzadok, Omer Bar Yosef, Dorit Granot and Lubov Blumkin. Their work appears in journals such as European Journal of Paediatric Neurology, Epilepsia, Journal of Child Neurology, Seizure and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.